tiprankstipranks
Regenerative Medical Technology Group (RMTG)
OTHER OTC:RMTG
US Market
Holding RMTG?
Track your performance easily

Regenerative Medical Technology Group (RMTG) Financial Statements

8 Followers

Regenerative Medical Technology Group Financial Overview

Regenerative Medical Technology Group's market cap is currently ―. The company's EPS TTM is $-0.414; its P/E ratio is -0.10; Regenerative Medical Technology Group is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 793.33K$ 817.03K$ 615.57K$ 646.83K$ 361.36K
Gross Profit$ 526.88K$ 568.99K$ 434.75K$ 450.29K$ 253.82K
EBIT$ -214.69K$ -60.84K$ -7.17M$ -4.20M$ -2.03M
EBITDA$ 899.72K$ 1.04M$ -6.31M$ -4.10M-
Net Income Common Stockholders$ -2.08M$ -1.96M$ -256.04K$ -5.86M$ -2.03M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 579.35K$ 530.54K$ 0.00$ 0.00
Total Assets$ 3.05M$ 3.08M$ 2.88M$ 3.31M$ 7.54M
Total Debt$ 17.42M$ 16.37M$ 15.23M$ 16.99M$ 7.12M
Net Debt$ 17.42M$ 15.79M$ 14.70M$ 16.99M$ 7.12M
Total Liabilities$ 28.88M$ 26.84M$ 24.67M$ 24.85M$ 23.22M
Stockholders Equity$ -25.83M$ -23.76M$ -21.80M$ -21.54M$ -15.68M
Cash Flow-
Free Cash Flow$ 37.74K$ 48.81K$ -313.40K$ -81.25K-
Operating Cash Flow$ 90.40K$ 107.97K$ -29.40K$ 10.14K$ -406.71K
Investing Cash Flow$ -52.66K$ -59.15K$ -284.00K$ -91.39K$ -4.72K
Financing Cash Flow--$ -300.00K--
Currency in USD

Regenerative Medical Technology Group Earnings and Revenue History

Regenerative Medical Technology Group Debt to Assets

Regenerative Medical Technology Group Cash Flow

Regenerative Medical Technology Group Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis